Rob Kania, Ph.D.

Dr. Kania is an accomplished biopharmaceutical leader and innovator with more than 25 years of experience discovering transformative small-molecule therapeutics for oncology and infectious disease. Recognized for his scientific rigor and collaborative leadership, he has contributed to multiple approved medicines that are helping patients around the world. Dr. Kania spent more than two decades at […]

Mariana Mihalusova, Ph.D.

Dr. Mihalusova is Vice President of Venture Healthcare at Venrock, where she focuses on biotech and pharmaceutical investments. She brings to Venrock deep experience spanning the entire spectrum of drug development – from preclinical, to marketing approval, to lifecycle management – with a special emphasis on crossing the chasm from discovery to clinical validation. She […]

Bob More

Mr. More is Managing Director at Alta Partners and brings more than 30 years of experience investing in life sciences companies. He currently serves on the boards of Amplitude Therapeutics, eGenesis, MBrace Therapeutics, SciThera, Tyra Biosciences, Variant Bio, and Vir Biotechnology. He also led Alta’s investment in Kelonia Therapeutics, which was acquired by Eli Lilly. […]

white logo.